Cargando…

Leitlinie: Neurogene Darmfunktionsstörung bei Querschnittlähmung (Langfassung): Entwicklungsstufe: S2k, AWMF-Register-Nr.: 179-004

The guidelines (AWMF register number: 179-004) on neurogenic bowel dysfunction (NBD) in spinal cord injury of the German-speaking Medical Society for Paraplegiology is addressed to all persons who care for people with congenital or acquired paraplegia with NBD. In particular, doctors, nurses and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Geng, Veronika, Böthig, Ralf, Hildesheim, Andreas, Kurze, Ines, Leder, Eckhart Dietrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484609/
https://www.ncbi.nlm.nih.gov/pubmed/32934429
http://dx.doi.org/10.1007/s00053-020-00482-5
_version_ 1783581005398933504
author Geng, Veronika
Böthig, Ralf
Hildesheim, Andreas
Kurze, Ines
Leder, Eckhart Dietrich
author_facet Geng, Veronika
Böthig, Ralf
Hildesheim, Andreas
Kurze, Ines
Leder, Eckhart Dietrich
author_sort Geng, Veronika
collection PubMed
description The guidelines (AWMF register number: 179-004) on neurogenic bowel dysfunction (NBD) in spinal cord injury of the German-speaking Medical Society for Paraplegiology is addressed to all persons who care for people with congenital or acquired paraplegia with NBD. In particular, doctors, nurses and therapists are addressed. The multiprofessionally developed guidelines (involving neurourologists, visceral surgeons, gastroenterologists, health and nursing staff, nutritionists and associated professional societies in the review process) provides practical support for the care of patients with NBD. Definitions and up to date knowledge on the diagnostics of NBD as well as on the necessary conservative bowel management are conveyed in order to ensure the competent treatment of patients with NBD. The concept of NBD and its clinical implications are described. Drug interventions and surgical procedures are explained in brief and recommendations are given. The main objective of the present guidelines is to prevent complications including fecal incontinence and constipation and thus to positively influence the quality of life of those affected. Helpful appendices, which can be used in everyday life, complete the guidelines.
format Online
Article
Text
id pubmed-7484609
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-74846092020-09-11 Leitlinie: Neurogene Darmfunktionsstörung bei Querschnittlähmung (Langfassung): Entwicklungsstufe: S2k, AWMF-Register-Nr.: 179-004 Geng, Veronika Böthig, Ralf Hildesheim, Andreas Kurze, Ines Leder, Eckhart Dietrich Coloproctology Leitlinien The guidelines (AWMF register number: 179-004) on neurogenic bowel dysfunction (NBD) in spinal cord injury of the German-speaking Medical Society for Paraplegiology is addressed to all persons who care for people with congenital or acquired paraplegia with NBD. In particular, doctors, nurses and therapists are addressed. The multiprofessionally developed guidelines (involving neurourologists, visceral surgeons, gastroenterologists, health and nursing staff, nutritionists and associated professional societies in the review process) provides practical support for the care of patients with NBD. Definitions and up to date knowledge on the diagnostics of NBD as well as on the necessary conservative bowel management are conveyed in order to ensure the competent treatment of patients with NBD. The concept of NBD and its clinical implications are described. Drug interventions and surgical procedures are explained in brief and recommendations are given. The main objective of the present guidelines is to prevent complications including fecal incontinence and constipation and thus to positively influence the quality of life of those affected. Helpful appendices, which can be used in everyday life, complete the guidelines. Springer Medizin 2020-09-11 2020 /pmc/articles/PMC7484609/ /pubmed/32934429 http://dx.doi.org/10.1007/s00053-020-00482-5 Text en © Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Leitlinien
Geng, Veronika
Böthig, Ralf
Hildesheim, Andreas
Kurze, Ines
Leder, Eckhart Dietrich
Leitlinie: Neurogene Darmfunktionsstörung bei Querschnittlähmung (Langfassung): Entwicklungsstufe: S2k, AWMF-Register-Nr.: 179-004
title Leitlinie: Neurogene Darmfunktionsstörung bei Querschnittlähmung (Langfassung): Entwicklungsstufe: S2k, AWMF-Register-Nr.: 179-004
title_full Leitlinie: Neurogene Darmfunktionsstörung bei Querschnittlähmung (Langfassung): Entwicklungsstufe: S2k, AWMF-Register-Nr.: 179-004
title_fullStr Leitlinie: Neurogene Darmfunktionsstörung bei Querschnittlähmung (Langfassung): Entwicklungsstufe: S2k, AWMF-Register-Nr.: 179-004
title_full_unstemmed Leitlinie: Neurogene Darmfunktionsstörung bei Querschnittlähmung (Langfassung): Entwicklungsstufe: S2k, AWMF-Register-Nr.: 179-004
title_short Leitlinie: Neurogene Darmfunktionsstörung bei Querschnittlähmung (Langfassung): Entwicklungsstufe: S2k, AWMF-Register-Nr.: 179-004
title_sort leitlinie: neurogene darmfunktionsstörung bei querschnittlähmung (langfassung): entwicklungsstufe: s2k, awmf-register-nr.: 179-004
topic Leitlinien
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484609/
https://www.ncbi.nlm.nih.gov/pubmed/32934429
http://dx.doi.org/10.1007/s00053-020-00482-5
work_keys_str_mv AT gengveronika leitlinieneurogenedarmfunktionsstorungbeiquerschnittlahmunglangfassungentwicklungsstufes2kawmfregisternr179004
AT bothigralf leitlinieneurogenedarmfunktionsstorungbeiquerschnittlahmunglangfassungentwicklungsstufes2kawmfregisternr179004
AT hildesheimandreas leitlinieneurogenedarmfunktionsstorungbeiquerschnittlahmunglangfassungentwicklungsstufes2kawmfregisternr179004
AT kurzeines leitlinieneurogenedarmfunktionsstorungbeiquerschnittlahmunglangfassungentwicklungsstufes2kawmfregisternr179004
AT ledereckhartdietrich leitlinieneurogenedarmfunktionsstorungbeiquerschnittlahmunglangfassungentwicklungsstufes2kawmfregisternr179004